Marc Casper, Thermo Fisher Scientific CEO (Photo by Suzanne Kreiter/The Boston Globe via Getty Images)
February 1, 2023 04:21 PM EST
Pharma
Manufacturing

Af­ter a busy year of build­outs, Ther­mo Fish­er sets plans for growth in 2023

Tyler Patchen

News Reporter

Last year, Ther­mo Fish­er ex­pand­ed wide­ly across the US and abroad. This year, how­ev­er, it’s ex­pect­ing a big dip in vac­cine and ther­a­peu­tics rev­enue. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Bris­tol My­ers re­veals more job cuts in New Jer­sey

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Cas­sa­va shares plunge as con­tro­ver­sial Alzheimer’s drug fails Phase 3 tri­al

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

A service from the Financial Times